Robert E. Mosser

Array ( [id] => 7988161 [patent_doc_number] => 08076375 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-13 [patent_title] => 'Methods of inhibiting poxvirus growth' [patent_app_type] => utility [patent_app_number] => 12/090081 [patent_app_country] => US [patent_app_date] => 2006-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 10 [patent_no_of_words] => 24981 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/076/08076375.pdf [firstpage_image] =>[orig_patent_app_number] => 12090081 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5220248 [patent_doc_number] => 20070161559 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-12 [patent_title] => 'METHOD FOR THE TREATMENT OF GOUT OR PSEUDOGOUT' [patent_app_type] => utility [patent_app_number] => 11/539851 [patent_app_country] => US [patent_app_date] => 2006-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8126 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20070161559.pdf [firstpage_image] =>[orig_patent_app_number] => 11539851 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5485763 [patent_doc_number] => 20090275528 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'ANTITUBERCULOUS COMPOSITION COMPRISING OXAZOLE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/088867 [patent_app_country] => US [patent_app_date] => 2006-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16506 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20090275528.pdf [firstpage_image] =>[orig_patent_app_number] => 12088867 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5205645 [patent_doc_number] => 20070027127 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-01 [patent_title] => 'Treatment of inflammatory oral diseases with a combination of inhibitors of TNF-alpha and immunosuppressive agents' [patent_app_type] => utility [patent_app_number] => 11/542526 [patent_app_country] => US [patent_app_date] => 2006-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1334 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20070027127.pdf [firstpage_image] =>[orig_patent_app_number] => 11542526 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9503626 [patent_doc_number] => 08741940 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-03 [patent_title] => 'Microbicidal composition' [patent_app_type] => utility [patent_app_number] => 11/529199 [patent_app_country] => US [patent_app_date] => 2006-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18903 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11529199 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7966425 [patent_doc_number] => 07939537 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-10 [patent_title] => 'HIV integrase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/992531 [patent_app_country] => US [patent_app_date] => 2006-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18333 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/939/07939537.pdf [firstpage_image] =>[orig_patent_app_number] => 11992531 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5241747 [patent_doc_number] => 20070020239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-25 [patent_title] => 'HEXIMI as a suppressor of HIV replication and cardiac hypertrophy' [patent_app_type] => utility [patent_app_number] => 11/526452 [patent_app_country] => US [patent_app_date] => 2006-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7720 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20070020239.pdf [firstpage_image] =>[orig_patent_app_number] => 11526452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5436259 [patent_doc_number] => 20090170846 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'INHIBITORS OF THE HIV INTEGRASE ENZYME' [patent_app_type] => utility [patent_app_number] => 12/088583 [patent_app_country] => US [patent_app_date] => 2006-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29538 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20090170846.pdf [firstpage_image] =>[orig_patent_app_number] => 12088583 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7530489 [patent_doc_number] => 07842711 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-30 [patent_title] => 'Indazolecarboxamide derivatives for the treatment and prevention of malaria' [patent_app_type] => utility [patent_app_number] => 11/531332 [patent_app_country] => US [patent_app_date] => 2006-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12702 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/842/07842711.pdf [firstpage_image] =>[orig_patent_app_number] => 11531332 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8244959 [patent_doc_number] => 08202889 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-19 [patent_title] => 'Inhibitors of bacterial IMPDH' [patent_app_type] => utility [patent_app_number] => 11/517755 [patent_app_country] => US [patent_app_date] => 2006-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14573 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/202/08202889.pdf [firstpage_image] =>[orig_patent_app_number] => 11517755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5141398 [patent_doc_number] => 20070003614 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => 'Pharmaceutical compositions comprising active vitamin D compounds' [patent_app_type] => utility [patent_app_number] => 11/516713 [patent_app_country] => US [patent_app_date] => 2006-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14829 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20070003614.pdf [firstpage_image] =>[orig_patent_app_number] => 11516713 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8749501 [patent_doc_number] => 08415334 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-09 [patent_title] => 'Method of combating infection' [patent_app_type] => utility [patent_app_number] => 11/991080 [patent_app_country] => US [patent_app_date] => 2006-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4734 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11991080 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6432695 [patent_doc_number] => 20100152230 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'HYDROXY SUBSTITUTED 1H-IMIDAZOPYRIDINES AND METHODS' [patent_app_type] => utility [patent_app_number] => 12/065490 [patent_app_country] => US [patent_app_date] => 2006-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32939 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20100152230.pdf [firstpage_image] =>[orig_patent_app_number] => 12065490 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5000474 [patent_doc_number] => 20070043108 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-22 [patent_title] => 'Use of equol for ameliorating or preventing neuropsychiatric and neurodegenerative diseases or disorders' [patent_app_type] => utility [patent_app_number] => 11/506443 [patent_app_country] => US [patent_app_date] => 2006-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 68 [patent_figures_cnt] => 68 [patent_no_of_words] => 22078 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20070043108.pdf [firstpage_image] =>[orig_patent_app_number] => 11506443 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6401652 [patent_doc_number] => 20100179161 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-15 [patent_title] => 'PYRAZOLINE DERIVATIVES FOR THE TREATMENT OF TURBERCULOSIS' [patent_app_type] => utility [patent_app_number] => 12/063740 [patent_app_country] => US [patent_app_date] => 2006-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12113 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0179/20100179161.pdf [firstpage_image] =>[orig_patent_app_number] => 12063740 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5890044 [patent_doc_number] => 20060276484 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'Use of selective dopamine D4 receptor agonists for treating sexual dysfunction' [patent_app_type] => utility [patent_app_number] => 11/504342 [patent_app_country] => US [patent_app_date] => 2006-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8541 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0276/20060276484.pdf [firstpage_image] =>[orig_patent_app_number] => 11504342 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5609120 [patent_doc_number] => 20060270636 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-30 [patent_title] => 'Methods for treatment of neuro- and nephro- disorders and therapeutic toxicities using aminothiol compounds' [patent_app_type] => utility [patent_app_number] => 11/501949 [patent_app_country] => US [patent_app_date] => 2006-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11278 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20060270636.pdf [firstpage_image] =>[orig_patent_app_number] => 11501949 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6424898 [patent_doc_number] => 20100168098 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'Viral Polymerase Inhibitors' [patent_app_type] => utility [patent_app_number] => 12/063468 [patent_app_country] => US [patent_app_date] => 2006-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21203 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0168/20100168098.pdf [firstpage_image] =>[orig_patent_app_number] => 12063468 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5465831 [patent_doc_number] => 20090326031 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'ANTIVIRAL USE OF CATIONIC SURFACTANT' [patent_app_type] => utility [patent_app_number] => 12/375774 [patent_app_country] => US [patent_app_date] => 2006-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2881 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0326/20090326031.pdf [firstpage_image] =>[orig_patent_app_number] => 12375774 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7687548 [patent_doc_number] => 20090176743 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'Methods for treating or preventing reactivation of a latent herpesvirus infection' [patent_app_type] => utility [patent_app_number] => 11/989700 [patent_app_country] => US [patent_app_date] => 2006-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 21116 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20090176743.pdf [firstpage_image] =>[orig_patent_app_number] => 11989700 [rel_patent_id] =>[rel_patent_doc_number] =>)